Crinetics Pharmaceuticals CRNX Less than 12 months
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Crinetics Pharmaceuticals's less than 12 months?
- Crinetics Pharmaceuticals (CRNX) reported less than 12 months of $749.32M in Q1 2026.